Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Merck Research Laboratories

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 2
Rounds per year 0.18
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Clinical Trials
  • Health Diagnostics
  • Therapeutics
  • Medical
Summary

In 2004 was created Merck Research Laboratories, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Boston. The company was established in North America in United States.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Merck Research Laboratories, startups are often financed by Polaris Partners, Flagship Pioneering, Omega Funds. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, Polaris Partners. In the next rounds fund is usually obtained by Vertex Ventures HC, Vertex Ventures, Polaris Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Imago BioSciences, Visterra. The fund has no exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics.

The high activity for fund was in 2014. Opposing the other organizations, this Merck Research Laboratories works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Merck Research Laboratories:
Typical Co-investors
Merck Research Laboratories is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Merck Research Laboratories:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AO Capital Partners China, Hong Kong, Hong Kong Island
BLSW Seed and Growth Fund -
Carrot Capital California, San Francisco, United States
Center for Innovation Arlington, Texas, United States
Delphi Berkeley, California, United States
Discount Capital Israel, Tel Aviv, Tel Aviv District
DSL Capital -
Escalate Capital Partners Austin, Texas, United States
Fort Washington Capital Partners Group Cincinnati, Ohio, United States
Genesis Inventions, L.P. Austin, Texas, United States
Gilbert Global Equity Partners Jersey City, New Jersey, United States
Leo Sophia Japan, Tokyo
Primwest Geneva, Geneve, Switzerland
Profin Capital -
RCGI -
Referentia Systems Incorporated Hawaii, Honolulu, United States
Rhia Ventures California, San Francisco, United States
Waters Corporation Massachusetts, Milford, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Visterra

Biotechnology
Clinical Trials
Health Diagnostics
Therapeutics
$23M01 Jun 2016 Cambridge, Massachusetts, United States

Imago BioSciences

Biotechnology
Life Science
Medical
$26M31 Oct 2014 California, United States

Visterra

Biotechnology
Clinical Trials
Health Diagnostics
Therapeutics
$30M02 Oct 2014 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Merck Research Laboratories?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 26M
Rounds per year 0.18
Peak activity year 2014
Lead investments 0
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Visterra

Biotechnology
Clinical Trials
Health Diagnostics
Therapeutics
$23M01 Jun 2016 Cambridge, Massachusetts, United States

Imago BioSciences

Biotechnology
Life Science
Medical
$26M31 Oct 2014 California, United States

Visterra

Biotechnology
Clinical Trials
Health Diagnostics
Therapeutics
$30M02 Oct 2014 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: